What Can Machines Do That Lawyers Can’t? A.I. Applications for Law

Episode Summary: CEO Chris Nicholson speaks on Skymind machine learning applications, which integrate with Hadoop and Spark. In this episode, Nicholson sheds light on current machine learning trends that he sees across industries and best practices for implementing AI solutions in order to gain consistent return on investment. For our readers who enjoyed out consensus on future trends in artificial intelligence consumer applications, it may be interesting to hear some of Chris's specific use cases in industry.

When it comes to effectiveness of machine learning, more data almost always yields better results—and the healthcare sector is sitting on a data goldmine. McKinsey estimates that big data and machine learning in pharma and medicine could generate a value of up to $100B annually, based on better decision-making, optimized innovation, improved efficiency of research/clinical trials, and new tool creation for physicians, consumers, insurers, and regulators.
Where does all this data come from? If we could look at labeled data streams, we might see research and development (R&D); physicians and clinics; patients; caregivers; etc. The array of (at present) disparate origins is part of the issue in synchronizing this information and using it to improve healthcare infrastructure and treatments. Hence, the present-day core issue at the intersection of machine learning and healthcare: finding ways to effectively collect and use lots of different types of data for better analysis, prevention, and treatment of individuals.
Burgeoning applications of ML in pharma and medicine are glimmers of a potential future in which synchronicity of data, analysis, and innovation are an everyday reality.
At Emerj, the AI Research and Advisory Company, we research how AI is impacting the pharmaceutical industry as part of our AI Opportunity Landscape service. Global pharma companies use AI Opportunity Landscapes to find out where AI fits at their company and which AI applications are driving value in the industry.
In this article, we use insights from our research to provide a breakdown of several of the pioneering applications of AI in pharma and areas for continued innovation.

As the term "machine learning" has heated up, interest in "robotics" (as expressed in Google Trends) has not altered much over the last three years. So how much of a place is there for machine learning in robotics?

Human resources has been slower to come to the table with machine learning and artificial intelligence than other fields—marketing, communications, even health care. But the value of machine learning in human resources can now be measured, thanks to advances in algorithms that can predict employee attrition, for example, or deep learning neural networks that are edging toward more transparent reasoning in showing why a particular result or conclusion was made.

Episode Summary: A lot of companies in the San Francisco Bay area make the claim that they can do something great with data; many fewer are at a degree of scale to make this vision possible. Today we speak with Nicholas Clark, CEO of DoubleDutch, a company now powering thousands of events nationally and implementing machine learning into their operations, including predicting business results from actual attendees. DoubleDutch is at the beginning of its journey with predictive analytics, having to make hard choices around what sort of information and thought processes they need in order to use machine learning and remain profitable. Nicholas gives his perspective on these decisions, as well as how he thinks DoubleDutch’s efforts will impact the conference/event industry at scale.